1-ethyl-1-phenylpropylamine | 30568-46-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-ethyl-1-phenylpropylamine
• 英文别名: 3-amino-3-phenylpentane；α,α-Diethylbenzylamine；1-ethyl-1-phenyl-propylamine；1-Aethyl-1-phenyl-propylamin；3-Amino-3-phenyl-pentan；Phenyl-3-amino-3-pentan；3-Phenylpentan-3-amine
• CAS: 30568-46-8
• 化学式: C₁₁H₁₇N
• 分子量: 163.263
• InChiKey: JOGPHRRMASCZSC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-ethyl-1-phenylpropylamine 在 盐酸 、 sodium acetate 、 三乙酰氧基硼氢化钠 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 、 水 、 乙酸乙酯 、 乙腈 为溶剂， 反应 89.0h， 生成 N-(3-phenylpentan-3-yl)-1-(2-phenylethyl)piperidine-4-carboxamide fumarate
  参考文献：
  名称：

  Synthesis and Pharmacological Evaluation of 1-Alkyl-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]piperidine-4-carboxamide Derivatives as Novel Antihypertensive Agents

  摘要：

  我们合成并评估了一系列1-烷基-N-[(1R)-1-(4-氟苯基)-2-甲基丙基]哌啶-4-羧酰胺衍生物对T型钙通道的抑制活性。结构-活性关系研究表明，苄位异丙基取代基在发挥强效抑制活性中起着重要作用，并且苄位的绝对构型与作为新型T型钙通道阻滞剂首次上市的米贝地尔相反。N-[(1R)-1-(4-氟苯基)-2-甲基丙基]-1-[2-(3-甲氧基苯基)乙基]哌啶-4-羧酰胺（17f）的口服给药能降低自发性高血压大鼠的血压，而不会引起反射性心动过速，这是传统L型钙通道阻滞剂常见的不良反应。

  DOI：

  10.1248/cpb.59.1376
• 作为产物：
  描述：

  1-ethyl-1-phenyl-propyl isocyanate 在 盐酸 作用下， 生成 1-ethyl-1-phenylpropylamine
  参考文献：
  名称：

  Montagne; Casteran, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1930, vol. 191, p. 139

  摘要：

  DOI：

文献信息

• Antibacterial water-soluble cutting fluids resistant to yeast-like fungi
  申请人：YUSHIRO CHEMICAL INDUSTRY CO. LTD.

  公开号：EP0388320A1

  公开（公告）日：1990-09-19

  A bactericide is added to conventional water-soluble cutting fluids to suppress deterioration by micro­organisms. Such fluids are however accompanied by the drawbacks that the bactericide has a narrow antibacterial spectrum and moreover its effects last a short time. It is the object of the present invention to offers water-­soluble cutting fluids which remain resistant to a wide variety of microorganisms for a long time. The present invention therefore offers water-soluble cutting fluids to which has been added a specific amine selected from amines known to date.

  将细菌杀灭剂添加到传统的水溶性切削液中，以抑制微生物的腐败。然而，这种液体伴随着细菌杀灭剂的缺点，即细菌杀灭剂的抗菌谱较窄，而且其效果持续时间较短。本发明的目的是提供一种长时间保持对各种微生物具有抗性的水溶性切削液。因此，本发明提供了一种水溶性切削液，其中添加了一种特定的胺，该胺是从迄今为止已知的胺中选择的。
• Steroid derivatives for the treatment of prostatic hypertrophy their
  申请人：Sankyo Company, Limited

  公开号：US05536714A1

  公开（公告）日：1996-07-16

  The invention includes compounds of formula (I): ##STR1## in which R.sup.1 is hydrogen, alkyl, aryl-substituted alkyl or aromatic heterocyclic-substituted alkyl; R.sup.2 is aryl-substituted alkyl, aromatic heterocyclic-substituted alkyl or diarylamino; and R.sup.3 is carboxy or a group of formula --CONHSO.sub.2 R.sup.4 wherein R.sup.4 is alkyl; and pharmaceutically acceptable salts and esters of the compounds. The compounds have valuable 5.alpha.-reductase inhibitory activity and can thus be used for the treatment and prophylaxis of, inter alia, prostatic hypertrophy as well as other disorders arising from excess levels of 5.alpha.-dihydro-testosterone.

  该发明包括式(I)的化合物：##STR1##其中R.sup.1是氢，烷基，芳基取代的烷基或芳香杂环基取代的烷基；R.sup.2是芳基取代的烷基，芳香杂环基取代的烷基或二芳基胺基；R.sup.3是羧基或具有式--CONHSO.sub.2 R.sup.4的基团，其中R.sup.4是烷基；以及该化合物的药用可接受盐和酯。这些化合物具有有价值的5α-还原酶抑制活性，因此可用于治疗和预防前列腺肥大等疾病，以及由于5α-二氢睾酮水平过高而引起的其他疾病。
• One-Pot Synthesis of Primary <i>tert</i>-Alkylamines by the Addition of Organometallic Reagents to Nitriles Mediated by Ti(O<i>i</i>-Pr)₄
  作者：Viktor Sokolov、Armin de Meijere、Olesya Tomashenko、Alexander Tomashevskiy

  DOI：10.1055/s-2007-967980

  日期：——

  A number of primary tert-alkylamines (18 examples, 25-72% yields) have been prepared according to a simple one-pot procedure by the addition of organometallic reagents such as Grignard reagents and organolithium compounds to nitriles in the presence of Ti(Oi-Pr)4.

  通过简单的一锅法步骤，在Ti(Oi-Pr)4的存在下，将格氏试剂和有机锂化合物等有机金属试剂添加到腈中，已制备了多种伯叔烷基胺（18个实例，产率25-72%）。
• Synthesis and anticonvulsant activity of 1-phenylcyclohexylamine analogs
  作者：Andrew Thurkauf、Brian De Costa、Shunichi Yamaguchi、Mariena V. Mattson、Arthur E. Jacobson、Kenner C. Rice、Michael A. Rogawski

  DOI：10.1021/jm00167a027

  日期：1990.5

  moderate correlation with the affinities for PCP sites. Several analogues exhibited a greater separation of potencies in the motor toxicity and MES seizure tests than did the parent compound PCA. These were obtained by (i) 3-methylation of the cyclohexyl ring trans to the phenyl ring, (ii) methoxylation at the ortho position on the phenyl ring, and (iii) contraction of the cyclohexane ring to form the corresponding

  在小鼠最大电击（MES）癫痫发作试验和运动毒性试验中，检查了38种1-苯基环己胺（PCA），苯环利定（PCP）衍生物的活性。此外，我们确定了化合物对大鼠脑膜中用[3H] -1- [1-（2-（2-噻吩基）环己基]哌啶标记的PCP受体位点的结合亲和力。许多类似物可预防MES发作（ED50为5-41 mg / kg，ip），所有这些化合物均引起运动毒性。运动毒性和MES发作测试的效力与PCP部位的亲和力呈中等程度的相关性。与母体化合物PCA相比，几种类似物在运动毒性和MES癫痫发作试验中表现出更大的效价分离。
• METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION
  申请人：Balensiefer Tim

  公开号：US20100081798A1

  公开（公告）日：2010-04-01

  The present invention relates to a process for preparing glucose from a lignocellulose-comprising starting material, in which this is firstly treated with an ionic liquid and subsequently subjected to an enzymatic hydrolysis. The invention further relates to a process for preparing microbial metabolites, especially ethanol, in which the glucose obtained is additionally subjected to a fermentation.

  本发明涉及一种从含木质纤维素的起始物质制备葡萄糖的过程，首先将其与离子液体处理，然后经酶解处理。该发明还涉及一种制备微生物代谢产物，特别是乙醇的过程，其中所获得的葡萄糖额外经过发酵处理。